Analyst Reco. Centene Corporation

Equities

CNC

US15135B1017

Market Closed - Nyse Other stock markets 03:59:59 2024-06-10 pm EDT			5-day change	1st Jan Change
69.83 ^USD	+0.03%		-2.00%	-6.07%

Jun. 05	Agilon Health Names Jeff Schwaneke CFO	MT
May. 31	Stephens Adjusts Price Target on Centene to $77 From $83	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Stephens Adjusts Price Target on Centene to $77 From $83	May. 31	MT
Baird Initiates Centene With Neutral Rating, $83 Price Target	May. 30	MT
Barclays Adjusts Price Target on Centene to $104 From $101	May. 02	MT
Bernstein Adjusts Centene's Price Target to $94 From $100	Apr. 30	MT
Deutsche Bank Adjusts Price Target on Centene to $82 From $81	Apr. 30	MT
Jefferies Adjusts Price Target on Centene to $90 From $94	Apr. 30	MT
Wells Fargo Raises Price Target on Centene to $93 From $89, Keeps Overweight Rating	Apr. 15	MT
Wells Fargo Lowers Price Target on Centene to $89 From $94, Maintains Overweight Rating	Apr. 08	MT
North American Morning Briefing : Stocks Struggle -2-	Mar. 22	DJ
Stephens Downgrades Centene to Equal-Weight From Overweight, Cuts Price Target to $85 From $92	Mar. 21	MT
Wells Fargo Raises Centene's Price Target to $94 From $90, Maintains Overweight Rating	Mar. 20	MT
Barclays Initiates Centene With Overweight Rating, Price Target is $101	Mar. 06	MT
Wall St set for muted open; earnings, rate-cut expectations in focus	Feb. 06	RE
Futures subdued with focus on pharma earnings, rate expectations	Feb. 06	RE
North American Morning Briefing : Rate Doubts Keep -2-	Feb. 06	DJ
MORNING BID AMERICAS-Rates rebound cools, China commands rally	Feb. 06	RE
Wells Fargo Upgrades Centene to Overweight From Equalweight, Boosts Price Target to $90 From $82	Jan. 02	MT
UBS Adjusts Centene Price Target to $79 From $72, Maintains Neutral Rating	Dec. 21	MT
Truist Securities Adjusts Price Target on Centene to $86 From $83, Keeps Buy Rating	Dec. 21	MT
Cantor Fitzgerald Adjusts Price Target on Centene to $90 From $82, Maintains Overweight Rating	Dec. 15	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

INTERVIEW - Sarah London, CEO of Centene: How can we reduce healthcare costs?

June 27, 2023 at 04:45 pm EDT